Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Biochemistry, Low Density Lipoprotein

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Biochemistry, Low Density Lipoprotein

Senthil K. Venugopal et al.
Free Books & Documents

Excerpt

Both cholesterol esters (CE) and triacylglycerols (TG) are insoluble in water (plasma); hence they are packaged as lipoproteins comprising an inner core of CE and TG with a surface coat of apolipoproteins, free cholesterol (FC), and phospholipids. Packaged as lipoproteins, they can be transported to various tissues where needed. By differing the lipid and protein concentrations, up to 5 different lipoproteins can be produced, such as chylomicrons, very-low-density lipoproteins (VLDL), intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). LDL is the predominant carrier of serum cholesterol (around 67%) and delivers it to tissues of need such as the adrenal glands, gonads, and other tissues. With a density of 1.019 to 1.063 g/ml, LDL contains 20% protein and 50% cholesterol (CE and FC) and displays beta mobility on electrophoresis. This review focuses on LDL, especially its biochemistry, measurement, and clinical significance.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Senthil Venugopal declares no relevant financial relationships with ineligible companies.

Disclosure: McDamian Anoruo declares no relevant financial relationships with ineligible companies.

Disclosure: Ishwarlal Jialal declares no relevant financial relationships with ineligible companies.

References

    1. Klein-Szanto AJP, Bassi DE. Keep recycling going: New approaches to reduce LDL-C. Biochem Pharmacol. 2019 Jun;164:336-341. - PubMed
    1. Zhong S, Li L, Shen X, Li Q, Xu W, Wang X, Tao Y, Yin H. An update on lipid oxidation and inflammation in cardiovascular diseases. Free Radic Biol Med. 2019 Nov 20;144:266-278. - PubMed
    1. Zhao Y, Hasse S, Zhao C, Bourgoin SG. Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases. Biochem Pharmacol. 2019 Jun;164:74-81. - PubMed
    1. Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019 Aug;234(10):16812-16823. - PubMed
    1. Pirahanchi Y, Anoruo M, Sharma S. StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2023. Jul 30, Biochemistry, Lipoprotein Lipase. - PubMed

Publication types

LinkOut - more resources